| Name | Paltimatrectinib |
|---|
| Description | Paltimatrectinib (compound I-147) is a potent tyrosine kinase inhibitor with an IC50 of <10 nM for tropomyosin kinases A (TrkA). Paltimatrectinib has the potential for cancer and inflammatory diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
TrkA |
| References |
| Molecular Formula | C20H15F5N6 |
|---|---|
| Molecular Weight | 434.37 |